UTHR vs. NBIX
Compare and contrast key facts about United Therapeutics Corporation (UTHR) and Neurocrine Biosciences, Inc. (NBIX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UTHR or NBIX.
Key characteristics
| UTHR | NBIX | |
|---|---|---|
| YTD Return | 82.11% | -3.48% |
| 1Y Return | 79.70% | 18.66% |
| 3Y Return (Ann) | 25.50% | 13.13% |
| 5Y Return (Ann) | 35.38% | 2.78% |
| 10Y Return (Ann) | 12.35% | 21.05% |
| Sharpe Ratio | 2.91 | 0.40 |
| Sortino Ratio | 3.67 | 0.72 |
| Omega Ratio | 1.52 | 1.12 |
| Calmar Ratio | 3.24 | 0.49 |
| Martin Ratio | 10.71 | 1.23 |
| Ulcer Index | 7.52% | 10.93% |
| Daily Std Dev | 27.77% | 32.91% |
| Max Drawdown | -93.18% | -97.21% |
| Current Drawdown | -2.33% | -16.96% |
Fundamentals
| UTHR | NBIX | |
|---|---|---|
| Market Cap | $17.88B | $12.88B |
| EPS | $22.76 | $3.75 |
| PE Ratio | 17.59 | 33.91 |
| PEG Ratio | 1.77 | 0.30 |
| Total Revenue (TTM) | $2.76B | $2.24B |
| Gross Profit (TTM) | $2.45B | $2.20B |
| EBITDA (TTM) | $1.51B | $614.00M |
Correlation
The correlation between UTHR and NBIX is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
UTHR vs. NBIX - Performance Comparison
In the year-to-date period, UTHR achieves a 82.11% return, which is significantly higher than NBIX's -3.48% return. Over the past 10 years, UTHR has underperformed NBIX with an annualized return of 12.35%, while NBIX has yielded a comparatively higher 21.05% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
UTHR vs. NBIX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
UTHR vs. NBIX - Dividend Comparison
Neither UTHR nor NBIX has paid dividends to shareholders.
Drawdowns
UTHR vs. NBIX - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, roughly equal to the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for UTHR and NBIX. For additional features, visit the drawdowns tool.
Volatility
UTHR vs. NBIX - Volatility Comparison
United Therapeutics Corporation (UTHR) and Neurocrine Biosciences, Inc. (NBIX) have volatilities of 8.92% and 9.02%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
UTHR vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities